Announcements Trials
Browse Landscape

Status

Unknown 3Completed 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 45Observational 5

Sponsor

Cancer Type

Gynecologic 4Other hematologic neoplasm 1Lymphoid 1

Conditions

Ovarian Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 447Surgical Procedures, Operative 164Observation 152Drug Therapy 143Radiotherapy 142Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 79Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 67Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 62Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × 1-dodecylpyridoxal × Clear all
NCT05976932 2023-08-04

Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer

Fudan University

Unknown
20 enrolled
Gynecologic

Ovarian Neoplasms

NCT05868889 2023-05-24

Retrospective Multicenter Study of Elderly Patients With Ovarian Cancer Treated With Trabectedin and PLD

Grupo Español de Investigación en Cáncer de Ovario

Completed
43 enrolled
Gynecologic

Ovarian Neoplasms

NCT03562533 2019-02-28

Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer

Konkuk University Medical Center

Completed
432 enrolled
Gynecologic

Ovarian Neoplasms

NCT03446495 2018-02-26

Renaissance

Scientific Medical Society, Kazakhstan

Unknown
60 enrolled
Gynecologic

Ovarian Neoplasms

NCT03419494 2018-02-05

Comparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL Patients

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown
40 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡